glp 1 receptor agonist structure GLP-1 2 | CAS NO.:2230197-64-3 Glucagon-like peptide-1 receptor - Wikipedia
Description
Specifically, mutagenesis of ECD, ECL1 and ECL3 individually increased the basal activity of GCGR, which could result from the interruption of intramolecular interactions between the ECD and ECL1/3 that otherwise stabilize the receptor in an inactive state
Lanzinger S, Breitner S, Neas L, Cascio W, Diaz-Sanchez D, Hinderliter A, et al
Green JB, Bethel MA, Armstrong PW, et al
What GLP-1 is best for weight loss
In a randomised, placebo-controlled double blinded phase 1 study of ascending single doses in healthy overweight humans, cotadutide was shown to be safe and, in common with the GLP-1 analogues, to be associated with dose-dependent gastrointestinal adverse events especially nausea and vomiting
